Billing, Heiko <br/><br/>
Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial.  [electronic resource] 

 -  Therapeutic drug monitoring  02 2017 
 - 21-28 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1536-3694 
<br/><br/><label>Standard No.: </label>10.1097/FTD.0000000000000361  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Alleles<br/>Area Under Curve<br/>Child<br/>Child, Preschool<br/>Cytochrome P-450 CYP3A--genetics<br/>Dose-Response Relationship, Drug<br/>Female<br/>Gene Frequency<br/>Genotype<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Kidney Transplantation--methods<br/>Male<br/>Multidrug Resistance-Associated Protein 2<br/>Mycophenolic Acid--administration & dosage<br/>Pharmacogenetics<br/>Polymorphism, Single Nucleotide<br/>Tacrolimus--administration & dosage<br/>Time Factors